Abbott Laboratories (ABT)

Abbott Laboratories (ABT $131.33)
- $131.33 P/E (TTM): 16.78X Cap: $232.75B
- View ABT Profile
- View Questions on ABT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $274.40)
- $274.40 P/E (TTM): 22.58X Cap: $147.72B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $112.54)
- $112.54 P/E (TTM): 22.77X Cap: $141.15B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $217.61)
- $217.61 P/E (TTM): 104.47X Cap: $385.71B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $131.33)
- $131.33 P/E (TTM): 16.78X Cap: $232.75B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $297.14)
- $297.14 P/E (TTM): 16.64X Cap: $80.81B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $177.40)
- $177.40 P/E (TTM): 19.04X Cap: $427.23B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $93.43)
- $93.43 P/E (TTM): 26.05X Cap: $119.84B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $20.78)
- $20.78 P/E (TTM): 26.64X Cap: $1.48B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

Abbott Laboratories (ABT $131.33)
- $131.33 P/E (TTM): 16.78X Cap: $232.75B
- View ABT Profile
- View Questions on ABT

Q: I own ABT, and it’s down 8% today. Would it be a good idea to add to it? Thank you,

Read Answer Asked by Gervais on July 18, 2025

Intuitive Surgical Inc. (ISRG $433.99)
- $433.99 P/E (TTM): 62.63X Cap: $161.19B
- View ISRG Profile
- View Questions on ISRG
Abbott Laboratories (ABT $131.33)
- $131.33 P/E (TTM): 16.78X Cap: $232.75B
- View ABT Profile
- View Questions on ABT
Becton Dickinson and Company (BDX $185.74)
- $185.74 P/E (TTM): 34.07X Cap: $53.55B
- View BDX Profile
- View Questions on BDX
Boston Scientific Corporation (BSX $99.87)
- $99.87 P/E (TTM): 61.14X Cap: $152.19B
- View BSX Profile
- View Questions on BSX
iShares U.S. Medical Devices ETF (IHI $60.34)
- $60.34 P/E (TTM): 28.37X Cap: $4.26B
- View IHI Profile
- View Questions on IHI

Q: Comments on earnings and if buy, sell or hold. What is happening with medical devices in the current economic environment? Thank you!

Read Answer Asked by Neil on May 06, 2025